References
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011 Mar;144:646–674.
- Morgenstern D, Anderson J. The immune response in paediatric cancer. Open Pathology J 2010;4:45–59.
- Vakkila J, Jaffe R, Michelow M, Lotze MT. Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors. Clin Cancer Res 2006 Apr 1;12(7):2049–2054.
- Sica A, Larghi P, Mancino A, Macrophage polarization in tumour progression. Semin Cancer Biol 2008 Oct;18(5):349–355.
- Song L, Asgharzadeh S, Salo J, Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J Clin Invest 2009 Jun;119(6):1524–1536.
- Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009 Mar;9(3):162–174.
- Martin RF, Beckwith JB. Lymphoid infiltrates in neuroblastomas: their occurrence and prognostic significance. J Pediatr Surg 1968 Feb;3(1):161–164.
- Coughlin CM, Fleming MD, Carroll RG, Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma. J Clin Oncol 2006 Dec 20;24(36):5725–5734.
- Lauder I, Aherne W. The significance of lymphocytic infiltration in neuroblastoma. Br J Cancer 1972 Aug;26(4):321–330.
- Cooper R, Khakoo Y, Matthay KK, Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med Pediatr Oncol 2001 Jun;36(6):623–629.
- Johnson BD, Jing W, Orentas RJ. CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma. J Immunother 2007 Mar;30(2):203–214.
- Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009 Nov;9(11):798–809.
- Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007 Jan;7(1):41–51.
- Zeng M, Cui Y, Wu C. Expression of SSTR2 and P-STAT3 in human olfactory neuroblastoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Aug;24(15):690–692.
- Cattaneo E, Magrassi L, De-Fraja C, Variations in the levels of the JAK/STAT and ShcA proteins in human brain tumors. Anticancer Res 1998 Aug;18(4A):2381–2387.
- Schaefer LK, Ren Z, Fuller GN, Schaefer TS. Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene 2002 Mar 27;21(13):2058–2065.
- Chen C-L, Loy A, Cen L, Signal transducer and activator of transcription 3 is involved in cell growth and survival of human rhabdomyosarcoma and osteosarcoma cells. BMC Cancer 2007;7:111.
- Niu ZB Z-B, Wang CL, Hou Y, Yang Y, et al. Expression of stat3, HIF1alpha and VEGF in Wilms’ Tumor. Chinese J Contempor Pediatr 2007;9(5):461–464.
- Behjati S, Basu BP, Wallace R, STAT3 Regulates Proliferation and Immunogenicity of the ewing family of tumors In Vitro. Sarcoma 2012;2012:1–6.
- Morgenstern DA, Hasan F, Gibson S, PAX5 expression in nonhematopoietic tissues. Reappraisal of previous studies. Am J Clin Pathol 2010 Mar;133(3):407–415.
- Denkert C, Loibl S, Noske A, Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. JCO 2010 Jan 1;28(1):105–113.
- Rahir G, Moser M. Tumor microenvironment and lymphocyte infiltration. Cancer Immunol, Immunother: CII [Internet]. 2012 Jun;61(6):751–759.
- Oble DA, Loewe R, Yu P, Mihm Jr MC. Focus on TILS: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immunity 2009;9:3.
- Shablak A, Hawkins RE, Rothwell DG, Elkord E. T cell-based immunotherapy of metastatic renal cell carcinoma: modest success and future perspective. Clin. Cancer Res. 2009 Nov 1;15(21):6503–6510.
- Nabarro S, Himoudi N, Papanastasiou A, Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein. J Exp Med 2005 Nov 21;202(10):1399–1410.